Home » Ethics, Trade
Email This Post | Print this post

Tainted drugs from China?

Published: 17 June 2007 by CA

I am "CA" Atreya (PMP, MBA), the author of this blog. I help businesses in Atlantic Canada achieve their BHAG successfully. You may subscribe to this blog using a feed reader (RSS).

I recently came across this article in the New York Times - F.D.A. Tracked Tainted Drugs, but Trial Went Cold in China. The article is written by Walt Bogdanich - a Pilitzer Prize winner for national reporting in 2005 among other awards - along with other contributors.

“After a drug ingredient from China killed dozens of Haitian children a decade ago, a senior American health official sent a cable to her investigators: find out who made the poisonous ingredient and why a state-owned company in China exported it as a safe, pharmaceutical grade glycerin …”

It is sad that companies stoop to such immoral practices to get boost their profits. But it is also an important lesson for all to do your due diligence when dealing with businesses across countries - especially where the law is of little help.

Bookmark and Share
Other articles filed under Ethics, Trade categories.

Leave your response!

Add your comment below, or trackback from your own site. You can also subscribe to these comments via RSS.

Be nice. Keep it clean. Stay on topic. No spam.

You can use these tags:
<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

This is a Gravatar-enabled weblog. To get your own globally-recognized-avatar, please register at Gravatar.